J
Jeremy J Heit
Researcher at Stanford University
Publications - 227
Citations - 7499
Jeremy J Heit is an academic researcher from Stanford University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 24, co-authored 151 publications receiving 5728 citations. Previous affiliations of Jeremy J Heit include Partners HealthCare & Ohio State University.
Papers
More filters
Journal ArticleDOI
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
Gregory W. Albers,Michael P. Marks,Stephanie Kemp,Soren Christensen,Jenny P Tsai,Santiago Ortega-Gutierrez,Ryan A McTaggart,Michel T. Torbey,May Kim-Tenser,Thabele M Leslie-Mazwi,Amrou Sarraj,Scott E. Kasner,Sameer A. Ansari,Sharon D. Yeatts,Scott Hamilton,Michael Mlynash,Jeremy J Heit,Greg Zaharchuk,Sun Kim,Janice Carrozzella,Yuko Y. Palesch,Andrew M. Demchuk,Roland Bammer,Philip W. Lavori,Joseph P. Broderick,Maarten G Lansberg +25 more
TL;DR: Endovascular thrombectomy for ischemic stroke 6 to 16 hours after a patient was last known to be well plus standard medical therapy resulted in better functional outcomes than standard medical Therapy alone among patients with proximal middle‐cerebral‐artery or internal‐carotid‐arterY occlusion and a region of tissue that was ischeMIC but not yet infarcted.
Journal ArticleDOI
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
Joseph R. Arron,Monte M. Winslow,Alberto Polleri,Ching Pin Chang,Hai Wu,Xin Gao,Joel R. Neilson,Lei Chen,Jeremy J Heit,Seung K. Kim,Nobuyuki Yamasaki,Tsuyoshi Miyakawa,Uta Francke,Isabella A. Graef,Gerald R. Crabtree +14 more
TL;DR: It is suggested that the 1.5-fold increase in dosage of DSCR1 and DYRK1A cooperatively destabilizes a regulatory circuit, leading to reduced NFATc activity and many of the features of Down's syndrome, and the destabilization of regulatory circuits can underlie human disease.
Journal ArticleDOI
Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells.
TL;DR: Evidence is provided that embryonic stem cells can serve as the source of insulin-producing replacement tissue in an experimental model of diabetes mellitus and that strategies for producing cells that can replace islet functions described here can be adapted for similar uses with human cells.
Journal ArticleDOI
Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function
Jeremy J Heit,Åsa A. Apelqvist,Xueying Gu,Monte M. Winslow,Joel R. Neilson,Gerald R. Crabtree,Seung K. Kim +6 more
TL;DR: Calcineurin/NFAT signalling regulates multiple factors that control growth and hallmark β-cell functions, revealing unique models for the pathogenesis and therapy of diabetes.
Journal ArticleDOI
Menin Controls Growth of Pancreatic ß-Cells in Pregnant Mice and Promotes Gestational Diabetes Mellitus
Satyajit K. Karnik,Hainan Chen,Graeme W. McLean,Jeremy J Heit,Xueying Gu,Andrew Y. Zhang,Magali J. Fontaine,Michael H. Yen,Seung K. Kim +8 more
TL;DR: It is shown that menin, a protein previously characterized as an endocrine tumor suppressor and transcriptional regulator, controls islet growth in pregnant mice, expanding the understanding of mechanisms underlying diabetes pathogenesis and revealing potential targets for therapy in diabetes.